BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moffitt GB, Stewart RD, Sandison GA, Goorley JT, Argento DC, Jevremovic T, Emery R, Wootton LS, Parvathaneni U, Laramore GE. Dosimetric characteristics of the University of Washington Clinical Neutron Therapy System. Phys Med Biol 2018;63:105008. [PMID: 29637903 DOI: 10.1088/1361-6560/aabd52] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Goodhead DT. Neutrons are forever! Historical perspectives. Int J Radiat Biol 2019;95:957-84. [PMID: 30668204 DOI: 10.1080/09553002.2019.1569782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
2 Aljabab S, Lui A, Wong T, Liao J, Laramore G, Parvathaneni U. A Combined Neutron and Proton Regimen for Advanced Salivary Tumors: Early Clinical Experience. Cureus 2021;13:e14844. [PMID: 34104589 DOI: 10.7759/cureus.14844] [Reference Citation Analysis]
3 Gallagher KJ, Taddei PJ. Independent application of an analytical model for secondary neutron equivalent dose produced in a passive-scattering proton therapy treatment unit. Phys Med Biol 2018;63:15NT04. [PMID: 29978833 DOI: 10.1088/1361-6560/aad1bc] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Stewart RD. Induction of DNA Damage by Light Ions Relative to 60Co γ-rays. Int J Part Ther 2018;5:25-39. [PMID: 31773018 DOI: 10.14338/IJPT-18-00030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Mchale S, Decker A. Estimating radiation protection factor (RPF) values for a simple surrogate vehicle using the MCNP6.1 code. Applied Radiation and Isotopes 2019;153:108825. [DOI: 10.1016/j.apradiso.2019.108825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]